Literature DB >> 18223087

Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium.

Víctor A García-Angulo1, Wanyin Deng, Nikhil A Thomas, B Brett Finlay, Jose L Puente.   

Abstract

Together with enterohemorrhagic Escherichia coli and enteropathogenic Escherichia coli, Citrobacter rodentium is a member of the attaching-and-effacing (A/E) family of bacterial pathogens. A/E pathogens use a type III secretion system (T3SS) to translocate an assortment of effector proteins, encoded both within and outside the locus of enterocyte effacement (LEE), into the colonized host cell, leading to the formation of A/E lesions and disease. Here we report the identification and characterization of a new non-LEE encoded effector, NleH, in C. rodentium. NleH is conserved among A/E pathogens and shares identity with OspG, a type III secreted effector protein in Shigella flexneri. Downstream of nleH, genes encoding homologues of the non-LEE-encoded effectors EspJ and NleG/NleI are found. NleH secretion and translocation into Caco-2 cells requires a functional T3SS and signals located at its amino-terminal domain. Transcription of nleH is not significantly reduced in mutants lacking the LEE-encoded regulators Ler and GrlA; however, NleH protein levels are highly reduced in these strains, as well as in escN and cesT mutants. Inactivation of Lon, but not of ClpP, protease restores NleH levels even in the absence of CesT. Our results indicate that the efficient engagement of NleH in active secretion is needed for its stability, thus establishing a posttranslational regulatory mechanism that coregulates NleH levels with the expression of LEE-encoded proteins. A C. rodentium nleH mutant shows a moderate defect during the colonization of C57BL/6 mice at early stages of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223087      PMCID: PMC2293213          DOI: 10.1128/JB.01602-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  68 in total

1.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Identification of a negative regulator for the pathogenicity island of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Joaquim Chan-Wang Lio; Wan-Jr Syu
Journal:  J Biomed Sci       Date:  2004 Nov-Dec       Impact factor: 8.410

Review 3.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

4.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

5.  The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits.

Authors:  Jennifer M Ritchie; Matthew K Waldor
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens.

Authors:  Wanyin Deng; Yuling Li; Philip R Hardwidge; Elizabeth A Frey; Richard A Pfuetzner; Sansan Lee; Samantha Gruenheid; Natalie C J Strynakda; Jose L Puente; B Brett Finlay
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Bacteriophage-encoded type III effectors in Salmonella enterica subspecies 1 serovar Typhimurium.

Authors:  Kristin Ehrbar; Wolf-Dietrich Hardt
Journal:  Infect Genet Evol       Date:  2005-01       Impact factor: 3.342

Review 8.  Conserved features of type III secretion.

Authors:  A P Tampakaki; V E Fadouloglou; A D Gazi; N J Panopoulos; M Kokkinidis
Journal:  Cell Microbiol       Date:  2004-09       Impact factor: 3.715

9.  EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics.

Authors:  Sivan Dahan; Siouxsie Wiles; Roberto M La Ragione; Angus Best; Martin J Woodward; Mark P Stevens; Robert K Shaw; Yuwen Chong; Stuart Knutton; Alan Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

10.  Identification of Escherichia coli O157 : H7 genes influencing colonization of the bovine gastrointestinal tract using signature-tagged mutagenesis.

Authors:  Francis Dziva; Pauline M van Diemen; Mark P Stevens; Amanda J Smith; Timothy S Wallis
Journal:  Microbiology (Reading)       Date:  2004-11       Impact factor: 2.777

View more
  23 in total

Review 1.  Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host.

Authors:  Andrey M Grishin; Ksenia A Beyrakhova; Miroslaw Cygler
Journal:  Protein Sci       Date:  2015-02-06       Impact factor: 6.725

2.  A novel C-terminal region within the multicargo type III secretion chaperone CesT contributes to effector secretion.

Authors:  Thangadurai Ramu; Madhulika Esther Prasad; Erica Connors; Amit Mishra; Jenny-Lee Thomassin; Jason Leblanc; Jan K Rainey; Nikhil A Thomas
Journal:  J Bacteriol       Date:  2012-12-07       Impact factor: 3.490

3.  A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli.

Authors:  Víctor A García-Angulo; Verónica I Martínez-Santos; Tomás Villaseñor; Francisco J Santana; Alejandro Huerta-Saquero; Luary C Martínez; Rafael Jiménez; Cristina Lara-Ochoa; Juan Téllez-Sosa; Víctor H Bustamante; José L Puente
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

4.  The Type Three Secretion System 2-Encoded Regulator EtrB Modulates Enterohemorrhagic Escherichia coli Virulence Gene Expression.

Authors:  Deborah H Luzader; Graham G Willsey; Matthew J Wargo; Melissa M Kendall
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  Influence of NleH effector expression, host genetics, and inflammation on Citrobacter rodentium colonization of mice.

Authors:  Leigh Ann Feuerbacher; Philip R Hardwidge
Journal:  Microbes Infect       Date:  2014-03-05       Impact factor: 2.700

6.  Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97.

Authors:  Maike Schwidder; Michael Hensel; Herbert Schmidt
Journal:  J Bacteriol       Date:  2010-12-03       Impact factor: 3.490

7.  Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.

Authors:  Thanh H Pham; Xiaofei Gao; Karen Tsai; Rachel Olsen; Fengyi Wan; Philip R Hardwidge
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

8.  Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.

Authors:  Thanh H Pham; Xiaofei Gao; Gyanendra Singh; Philip R Hardwidge
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

9.  Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut.

Authors:  Cordula Hemrajani; Olivier Marches; Siouxsie Wiles; Francis Girard; Alison Dennis; Francis Dziva; Angus Best; Alan D Phillips; Cedric N Berger; Aurelie Mousnier; Valerie F Crepin; Laurens Kruidenier; Martin J Woodward; Mark P Stevens; Roberto M La Ragione; Thomas T MacDonald; Gad Frankel
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

10.  Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.

Authors:  Xiaofei Gao; Fengyi Wan; Kristina Mateo; Eduardo Callegari; Dan Wang; Wanyin Deng; Jose Puente; Feng Li; Michael S Chaussee; B Brett Finlay; Michael J Lenardo; Philip R Hardwidge
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.